WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009091) PURINE DERIVATIVES AS LIVER X RECEPTOR AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009091    International Application No.:    PCT/US2003/016016
Publication Date: 29.01.2004 International Filing Date: 20.05.2003
Chapter 2 Demand Filed:    22.12.2003    
IPC:
A61K 31/52 (2006.01), C07D 473/04 (2006.01), C07D 473/06 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; GlaxoSmithKline, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 ONN (GB) (For All Designated States Except US).
BOGGS, Sharon [US/US]; (US) (For US Only).
COLLINS, Jon, L [US/US]; (US) (For US Only).
FIVUSH, Adam [US/US]; (US) (For US Only).
STEWART, Eugene, Lee [US/US]; (US) (For US Only).
WILLSON, Timothy, Mark [GB/US]; (US) (For US Only)
Inventors: BOGGS, Sharon; (US).
COLLINS, Jon, L; (US).
FIVUSH, Adam; (US).
STEWART, Eugene, Lee; (US).
WILLSON, Timothy, Mark; (US)
Agent: LEVY, David, J; GlaxoSmithKline, Five Moore Drive, PO Box 13398, Research Triangle Park, NC 27709 (US)
Priority Data:
60/389,689 17.06.2002 US
Title (EN) PURINE DERIVATIVES AS LIVER X RECEPTOR AGONISTS
(FR) AGONISTES DES RECEPTEURS X DU FOIE
Abstract: front page image
(EN)The invention relates to methods for the treatment or prevention of an LXR mediated disease or condition, including cariovascular disease and atherosclerosis, novel compounds for use in such methods and pharmaceutical compositions comprising compounds for use in such methods.
(FR)L'invention concerne des procédés destinés au traitement ou à la prévention d'une maladie ou d'un état induit par LXR, notamment une maladie cardio-vasculaire et l'athérosclérose. L'invention concerne également des composés utiles dans de tels procédés et des compositions pharmaceutiques contenant ces composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)